Iconovo Dividend

Dividend criteria checks 0/6

Iconovo does not have a record of paying a dividend.

Key information

n/a

Dividend yield

n/a

Payout ratio

Industry average yield	1.7%
Next dividend pay date	n/a
Ex dividend date	n/a
Dividend per share	n/a
Earnings per share	-kr3.61
Dividend yield forecast in 3Y	12.3%

Recent dividend updates

No updates

Recent updates

Iconovo AB (publ)'s (STO:ICO) Intrinsic Value Is Potentially 37% Above Its Share Price

Jun 13

Companies Like Iconovo (STO:ICO) Can Afford To Invest In Growth

Apr 13

When Will Iconovo AB (publ) (STO:ICO) Turn A Profit?

Mar 18

Have Iconovo AB (publ) (STO:ICO) Insiders Been Selling Their Stock?

Feb 20

A Look At Iconovo's (STO:ICO) Share Price Returns

Feb 07

Have Insiders Been Buying Iconovo AB (publ) (STO:ICO) Shares?

Dec 21

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Insufficient data to determine if ICO's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if ICO's dividend payments have been increasing.

Dividend Yield vs Market

Iconovo Dividend Yield vs Market

How does ICO dividend yield compare to the market?
Segment	Dividend Yield
Company (ICO)	n/a
Market Bottom 25% (SE)	1.5%
Market Top 25% (SE)	4.3%
Industry Average (Medical Equipment)	1.7%
Analyst forecast in 3 Years (ICO)	12.3%

Notable Dividend: Unable to evaluate ICO's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate ICO's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate ICO's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: Unable to calculate sustainability of dividends as ICO has not reported any payouts.

Iconovo Dividend

Dividend criteria checks 0/6

Key information

Recent dividend updates

Recent updates

Iconovo AB (publ), Annual General Meeting, May 21, 2024

First quarter 2024 earnings released: kr0.69 loss per share (vs kr1.35 loss in 1Q 2023)

New major risk - Revenue and earnings growth

Iconovo AB (publ) has filed a Follow-on Equity Offering in the amount of SEK 18.8 million.

Iconovo AB (publ) to Report Q1, 2024 Results on Apr 25, 2024

New major risk - Market cap size

Insufficient new directors

New minor risk - Profitability

New major risk - Market cap size

Independent Chairman of the Board recently bought kr190k worth of stock

Third quarter 2023 earnings released: kr0.97 loss per share (vs kr1.14 loss in 3Q 2022)

Iconovo AB (publ) Completes Enrollment in Phase I Clinical Trial of Inhaled Oxytocin in ICOone

Iconovo AB (publ) Receives US Patent for Ioccap That Strengthens the Offering for More Customer Collaborations

Iconovo AB (Publ) Provides Earnings Guidance for the Years 2024, 2025, 2026 and 2027

New minor risk - Share price stability

New major risk - Financial position

Second quarter 2023 earnings released: kr1.36 loss per share (vs kr1.38 loss in 2Q 2022)

We're A Little Worried About Iconovo's (STO:ICO) Cash Burn Rate

Price target decreased by 27% to kr63.00

Iconovo AB (publ) Strengthens its Customer Offering in the Novel Pharmaceuticals Business Segment

Iconovo AB (Publ) Announces Appoints Carl Lindgren as Chief Business Development Officer

Independent Director recently sold kr98k worth of stock

Independent Director recently sold kr171k worth of stock

Chief Executive Officer recently bought kr61k worth of stock

Independent Chairman of the Board recently bought kr100k worth of stock

Iconovo AB (publ) to Report Fiscal Year 2022 Results on Feb 08, 2023

Insufficient new directors

Iconovo Receives Approval of New European Patent for Its Single-Use Inhaler ICOone®

Iconovo AB (publ) Announces Executive Changes, Effective April 1, 2023

Iconovo's ICOone Inhaler Platform Receives New Patent Approval in the US

Iconovo Announces Appointment of Nomination Committee

Third quarter 2022 earnings released: kr1.14 loss per share (vs kr0.43 loss in 3Q 2021)

Iconovo AB (publ) Conducts a User Study to Assess the Handling of its ICOone Nasal Inhaler

Here's Why We're Watching Iconovo's (STO:ICO) Cash Burn Situation

Second quarter 2022 earnings released: kr1.38 loss per share (vs kr0.85 loss in 2Q 2021)

Iconovo AB (Publ) Announces First Patent Grant in Japan for It's ICOone

Chief Executive Officer recently bought kr69k worth of stock

Director recently bought kr258k worth of stock

Chief Executive Officer recently bought kr104k worth of stock

Price target increased to kr140

Full year 2021 earnings: EPS and revenues miss analyst expectations

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Iconovo AB (publ) Announces Completion of Comparative Clinical Study of Icores Budesonide/Formoterol and Symbicort Turbuhaler

Chief Financial Officer recently bought kr53k worth of stock

Director recently bought kr78k worth of stock

No longer forecast to breakeven

Director recently bought kr109k worth of stock

Chairman of the Board recently bought kr372k worth of stock

Companies Like Iconovo (STO:ICO) Are In A Position To Invest In Growth

Chief Executive Officer recently bought kr151k worth of stock

Third quarter 2021 earnings released

Chairman of the Board recently bought kr248k worth of stock

Insider recently bought kr53k worth of stock

Chairman of the Board recently bought kr421k worth of stock

We're Not Worried About Iconovo's (STO:ICO) Cash Burn

Is Now The Time To Look At Buying Iconovo AB (publ) (STO:ICO)?

Chairman of the Board recently bought kr378k worth of stock

Iconovo AB (publ)'s (STO:ICO) Intrinsic Value Is Potentially 37% Above Its Share Price

Chairman of the Board recently bought kr689k worth of stock

First quarter 2021 earnings released

Companies Like Iconovo (STO:ICO) Can Afford To Invest In Growth

When Will Iconovo AB (publ) (STO:ICO) Turn A Profit?

Iconovo Granted ICOone Patent in India

Have Iconovo AB (publ) (STO:ICO) Insiders Been Selling Their Stock?

CTO, Co-Founder & Director recently sold kr1.1m worth of stock

Full year 2020 earnings released: kr2.20 loss per share (vs kr1.68 loss in FY 2019)

Revenue and earnings beat expectations

A Look At Iconovo's (STO:ICO) Share Price Returns

New 90-day high: kr54.60

Insider recently bought kr85k worth of stock

Iconovo Signs Agreement for Development of Inhaled Oxytocin in ICOone for Maternal Health

Have Insiders Been Buying Iconovo AB (publ) (STO:ICO) Shares?

Iconovo's Collaboration with Stevanato Marches on

Iconovo AB (publ) Announces Appointment of Nomination Committee

New 90-day low: kr49.50